Improving patient outcomes and clinical efficiency
Together with our customers and academic partners we support patient needs, patient value and clinical value at scale. We are actively building on existing evidence, carrying out clinical pilots and real world deployments, while regularly learning from our users.
Patient engagement and satisfaction
An early pilot study in the UK supported the feasibility and validity of high-frequency assessment of cognition and mood using wearable devices over an extended period in patients with major depressive disorder.Wearable Technology for High-Frequency Cognitive and Mood Assessment in Major Depressive Disorder: Longitudinal Observational Study. JMIR Mental Health.
A depression care pilot found differences in PAM-13 scores from baseline after 52 weeks, demonstrating significantly greater improvements in patient activation when using Fora Health compared to usual care.Mobile App to Enhance Patient Activation and Patient-Provider Communication in Major Depressive Disorder Management: Collaborative, Randomized Controlled Pilot Study. JMIR Formative Research.
We're also expecting encouraging results from an EMR-integrated pilot to be published in 2023.Use of a digitally enabled app With clinical team interface in the management of depression. ClinicalTrials.gov Identifier NCT04891224.
Clinical engagement and efficiency
Using Fora Health for depression care led to a 25% reduction in healthcare utilization by patients involved in shared decision-making, and data from the study was utilised by PCPs to inform clinical care.Mobile App to Enhance Patient Activation and Patient-Provider Communication in Major Depressive Disorder Management: Collaborative, Randomized Controlled Pilot Study. JMIR Formative Research.
Another study using Fora Health for depression found that app users felt more successful than control patients in achieving their personalized treatment goals. Care team and patient participants reported using the program data to assist in the SDM process.Mobile Technology-Supported Shared Decision-Making and Goal Setting for Management of Depression in Primary Care. The Annals of Family Medicine.
Opportunity to scale across treatments and diverse users
Fora Health can include content from any editorially approved decision aid, including EBSCO Option Grids which cover over 80 preference sensitive treatment decisions.My Health Decisions. EBSCO.
Shared decision-making leads to better outcomes
A review of over 33,000 patients found that patients with the lowest activation levels had predicted average costs that were 8 percent higher in the base year and 21 percent higher in the first half of the next year.Patients With Lower Activation Associated With Higher Costs; Delivery Systems Should Know Their Patients' 'Scores'. Health Affairs.
Shared decision-making increases patient engagement and activation. Detailed decision aids have been found to significantly improve patient knowledge compared to simple ones, allowing them to take a more active role in their healthcare.Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews.
Shared decision-making leads to greater clinical efficiency
Exposure to decision aids compared to usual care reduced the number of people choosing major elective invasive surgery, prostate-specific antigen screening and menopausal hormone therapy (in favour of more conservative options).Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews.
Physical healthcare costs can be reduced by $8k per patient per year for each patient being effectively treated for depression.Understanding the hidden costs of COVID-19’s potential impact on US healthcare. McKinsey.
Shared decision-making is scalable
Across a wide variety of decision contexts, people exposed to decision aids feel more knowledgeable, better informed, and clearer about their values.Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews.